Global Blood-Grouping Reagents Market Report 2024-2028, Featuring AliveDX, Atlas Medical, BAG Health Care, Calibre Scientific, Novacyt, QuidelOrtho, Rapid Labs, Paragon Care and VitroScient
18 avr. 2024 11h14 HE
|
Research and Markets
Dublin, April 18, 2024 (GLOBE NEWSWIRE) -- The "Global Blood-Grouping Reagents Market 2024-2028" report has been added to ResearchAndMarkets.com's offering. The latest market analysis predicts...
Global Blood Management and Diagnostics Market Size to Reach USD 7.48 Billion in 2032 | Emergen Research
26 sept. 2023 10h10 HE
|
Emergen Research
Vancouver, Sept. 26, 2023 (GLOBE NEWSWIRE) -- The global Blood Management and Diagnostics Market size was USD 4.40 Billion in 2022 and is expected to register a steady revenue CAGR of 5.4% during...
Blood Transfusion Diagnostics Market Hit $6.48Bn, Globally, by 2028 Growing at 6.9% CAGR, Says The Insight Partners
27 juil. 2022 10h30 HE
|
The Insight Partners
New York, July 27, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on "Blood Transfusion Diagnostics Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by...
Quotient Limited Announces CFO Transition
02 nov. 2016 16h15 HE
|
Quotient Limited
JERSEY, Channel Islands, Nov. 02, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, announced today that the company and Stephen Unger, Chief Financial...
Quotient Limited Reports Continued Progress on the Commercial Scale-up of MosaiQ™ and Second Quarter Fiscal 2017 Financial Results
31 oct. 2016 16h15 HE
|
Quotient Limited
JERSEY, Channel Islands, Oct. 31, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today reported further progress on the commercial scale-up of...
Quotient Limited Announces Booth Tour at the 2016 AABB Annual Meeting and Provides Update of Expected Timing of Internal Evaluation Study Results
21 oct. 2016 08h30 HE
|
Quotient Limited
JERSEY, Channel Islands, Oct. 21, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company’s executive management team will...
Quotient Limited to Report Second Quarter Fiscal 2017 Financial Results and Host Conference Call
17 oct. 2016 08h30 HE
|
Quotient Limited
JERSEY, Channel Islands, Oct. 17, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal...
Quotient Limited Announces $120 Million Secured Debt Financing
14 oct. 2016 16h01 HE
|
Quotient Limited
JERSEY, Channel Islands, Oct. 14, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (“Quotient”) (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the completion of a private...
Quotient Limited Announces Successful Validation of the Initial Manufacturing System for MosaiQ™ Microarrays
08 sept. 2016 16h05 HE
|
Quotient Limited
MosaiQTM manufacturing system operating in accordance with design requirements Ongoing evaluation of MosaiQTM methodology continues to demonstrate concordance levels in excess of 99.0% for key blood...
Quotient Limited Reports Further Progress on the Commercial Scale-up of MosaiQ™ and First Quarter Fiscal 2017 Financial Results
08 août 2016 16h15 HE
|
Quotient Limited
Facility modification completed – humidity control successfully resolved issue previously impacting final assembly of MosaiQ™ consumablesValidation of the initial manufacturing system for MosaiQ™...